Bone Marrow Cytogenetic Complete Remission Achieved by Interferon-α Plus Cytarabine Ocfosfate Therapy in a Patient With Chronic Myelogenous Leukemia During Extramedullary Blast Crisis
スポンサーリンク
概要
著者
-
OHYASHIKI Kazuma
First Department of Internal Medicine (Division of Hematology), Tokyo Medical University
-
MIYAZAWA Keisuke
First Department of Internal Medicine, Tokyo Medical University
-
UCHIDA Yoshiko
First Department of Internal Medicine
-
GOTOH Akihiko
First Department of Internal Medicine Tokyo Medical University
-
SASHIDA Goro
First Department of Internal Medicine, Tokyo Medical University
-
KAWAKUBO Ken
First Department of Internal Medicine, Tokyo Medical University
-
Ohyashiki K
Tokyo Medical Univ. Tokyo Jpn
-
Ohyashiki Kazuma
First Department Of Internal Medicine (division Of Hematology) Tokyo Medical University
-
Ohyashiki Kazuma
First Department Of Internal Medicine (hematology Division) Tokyo Medical University
-
Miyazawa Keisuke
日本医科大学 第三内科
-
Miyazawa Keisuke
First Department Of Internal Medicine Tokyo Medical University
-
GOTOH Akihiko
Hematology Division, Tokyo Medical University
-
Ohyashiki Kazuma
First Deparmtne Of Internal Medicine Tokyo Medical University
-
Kawakubo Ken
First Department Of Internal Medicine Tokyo Medical University
-
Sashida Goro
First Department Of Internal Medicine Tokyo Medical University
-
Gotoh Akihiko
Hematology Division Tokyo Medical University
-
Uchida Yoshiko
First Department Of Internal Medicine Tokyo Medical University
-
KIRIYAMA Yuzuru
First Department of Internal Medicine, Tokyo Medical University
-
Kuriyama Yuzuru
First Department Of Internal Medicine (division Of Hematology) Tokyo Medical University
関連論文
- Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutation
- Endobronchial Minute Leiomyoma in a Patient with Malignant Lymphoma
- Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells
- Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
- Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL : In vitro and in vivo studies
- Sustained Complete Cytogenetic Remission in a Patient with Chronic Myeloid Leukemia after Discontinuation of Imatinib Mesylate Therapy
- Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
- Apoptosis Induction Preceded by Mitochondrial Depolarization in Multiple Myeloma Cell Line U266 by 2-Aminophenoxazine-3-one(Medicinal Chemistry)
- Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload
- Disparity Between the Macroglobulin-Producing Components of 2 Cases of Follicular Lymphoma With Waldenstrom's Macroglobulinemia
- Localized diffuse large-cell lymphoma possibly coated with anti-tumor autoantibody: k λ-dual-positive lymphoma
- Homeobox genes in hematopoiesis and leukemogenesis
- Myeloid/Natural Killer Cell Precursor Acute Leukemia Accompanied by Homozygous Protein C Deficiency
- Can Eradication Therapy for Helicobacter pylori Really Inprove the Thrombocytopenia in Idiopathic Thrombocytopenic Purpura? Our Experience and a Literature Review
- Thrombocytopenia Induced by Imatinib Mesylate(Glivec) in Patients with Chronic Myelogenous Leukemia : Is 400 mg Daily of Imatinib Mesylate an Optimal Starting Dose for Japanese Patients?
- IgA-λ/IgG-к Biclonal Myeloma in which Two Clones Proliferated in Individual Sites
- A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
- Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia
- The Prophylactic Effect of Itraconazole Capsules and Fluconazole Capsules for Systemic Fungal Infections in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes : A Japanese Multicenter Randomized, Controlled Study
- The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
- Relapse of chronic myeloid leukemia-chronic phase 14 years after allogeneic hematopoietic stem cell transplantation
- Non-radioisotopic and Semi-quantitative Procedure for Terminal Repeat Amplification Protocol
- Trisomy 11 Acute Myeloid Leukemia: 5 Additional Cases From the Japan Adult Leukemia Study Group AML-92 and AML-95 Databases
- Hypereosinophilia in a Patient with Invasive Thymoma with Clonal T-Lymphocyte Expansion Expressing CD4, CD8, and CD25 Antigens
- Bone Marrow Cytogenetic Complete Remission Achieved by Interferon-α Plus Cytarabine Ocfosfate Therapy in a Patient With Chronic Myelogenous Leukemia During Extramedullary Blast Crisis
- Myelodysplastic Syndrome Accompanied by Addison's Disease and Multiple Autoimmune Phenomena: Steroid Therapy Resolved Cytopenias and All Immune Disorders
- Imatinib Mesylate in Combination with Other Chemotherapeutic Agents for Chronic Myelogenous Leukemia
- Brain Abscess in Acute Myeloid Leukemia
- Estimation of cardiac left ventricular ejection fraction in transfusional cardiac iron overload by R2^* magnetic resonance
- A Long-Survival Case of Systemic AL Amyloidosis with Nephrotic Syndrome
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- An Adult Case of Acute Disseminated Encephalomyelitis Accompanied with Measles Infection
- The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors
- 5q-syndrome in Japan
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes